| Sat 31 Jul 2010 |
Alberta scientists see Alzheimer's breakthrough
CBC | Scientists at the University of Lethbridge say they have successfully regrown adult brain cells in tests on mice, a breakthrough that could lead to treatment of neural diseases such as Alzheimer's. | "We're pretty excited by it," said Dr. Robert Su... |
DR ELLIE CANNON: What is NICE, and why does it have a nasty reputation?
The Daily Mail | NICE publishes guidelines on the use of new technologies that become available, including drugs | Last week the National Institute for Clinical Excellence (NICE) made headlines for refusing to fund dementia drugs for NHS patients, leaving Britain n... |
A pill to make you smarter? It may happen
Newsvine | New research suggests that this may eventually be possible. University of Maryland scientists have linked a brain compound called kynurenic acid to cognition, potentially opening the door to development of a drug that could aid learning in healthy ... |
T.I. And Tiny Marry In Three Cities
MTV | Hip-hop's king officially has his queen. Superstar rapper T.I. wed longtime girlfriend Tameka "Tiny" Cottle on Saturday (July 31). A representative for Tiny confirm to MTV News that the duo married in front of friends and family in Miami. | The cou... |
The lives of laborers and artists
Star Tribune | 'I Hotel," Karen Tei Yamashita's fourth novel, will be called many things, first of which will be brilliant, which it is. Due to its length and density, it will also be called "sprawling," which it isn't. Like James Joyce's modernist... |
Charlie Rich's songwriter widow dead at 76
MSNBC | LONDON (Hollywood Reporter) - Songwriter Margaret Ann Rich, widow of country music star Charlie Rich, died on Thursday at her home near Memphis, following a struggle with Alzheimer's disease. She was 76. | Her husband, who died in 1995, recorded se... |
Diabetic Man, 67, Missing In Ormond Beach
MSNBC | ORMOND BEACH, Fla. — WESH.com | Ormond Beach police are asking for the public's help in locating a 67-year-old man missing since at least 7 a.m. Wednesday. | Robert Shilt is diabetic and may be in the early stages of Alzheimer's disease. | Sh... |
Key target molecule for Alzheimer's therapy identified
Newstrack India | Washington, July 31 (ANI): Alzheimer patients have high accumulations of the beta-amyloid - appearing in the form of plaques - in their brain. The precursors of these plaques are thought to be the underlying cause of the nerve cell loss that leads ... |
Master Switch: The Molecular Power Behind Memory
redOrbit | Neuroscientists have long wondered how individual connections between brain cells remain diverse and "fit" enough for storing new memories. Reported in the prestigious science journal Neuron, a new study led by Dr. Inna Slutsky of the Sac... |
Love not forgotten
Tulsa World When Elaine Walsh walked in the door of her mother's assisted living home Wednesday, 90-year-old Julia Kribel began to cry that nobody liked her. | "What you do is give her a hug and a kiss," Walsh said. | And in an instant, the sadness is forgotten,... |
Editorial: Tackling head injuries
Philadelphia Daily News | The death this week of the pro football player nicknamed "The Assassin" for his brutal tackles, including one that crippled an opponent in 1978, is a poignant reminder that the dangers of the game as played in the National Football League... |
Local rock group plans fundraiser
Ohio | The local Christian rock band ICHTHUS will be in concert at 7 p.m. Aug. 7 at the Home Savings Bank Plaza Pavilion at East Main and North Water streets in downtown Kent. | The five-member band will be playing to benefit Habitat for Humanity, a nonpr... |
The complex of memory
Herald Tribune | 'Memory Wall," Anthony Doerr's second collection of stories, considers memory as a compulsion, a privilege, a sorrow and a mystery. The characters in these six stories struggle to recall loved ones who are gone, or choose to bury their memories, or... |
Letters: The limits of multiculturalism
The Independent | At a time when to express any view condemning the practices of non-Western religions means you are lumped in the same category as nationalist bigots, I welcomed Christina Patterson's article, "The limits of multiculturalism" (28 July). It was thoug... |
Senator Seeks Data on Complaints About Artificial Joints
The New York Times | A top Senate Republican is asking the nation’s biggest maker of artificial hips and knees to disclose information about how it handles complaints about possible product flaws from its medical consultants. | , the lawmaker, Senator Charles E. ... |
New NFL poster on concussions is a first step towards safety
The Grio | This is an Oct. 26, 2009, file photo showing Philadelphia Eagles tight end L.J. Smith holding his head after a hard hit by Atlanta Falcons' Lawyer Milloy during the fourth quarter of a football game in Philadelphia. Smith suffered a concussion and ... |
Out of touch and not very bright: Frank Vincent's verdict on judges
The Daily Telegraph Australia | SOME judges were intellectually or temperamentally unsuited to the job, according to one of Australia's most respected legal minds. | Retired Supreme Court judge Frank Vincent said some of his former colleagues stayed too long in the... |
| Fri 30 Jul 2010 |
Resverlogix Completes Dosing for ASSERT Trial
PR Newswire | Completion occurs 5 months ahead of schedule | TSX Exchange Symbol: RVX | CALGARY, May 12 /PRNewswire-FirstCall/ - Resverlogix is pleased to announce that the Phase 2 ASSERT clinical trial for its lead drug, RVX-208, a small molecule therapy... |
AFFiRiS AG: Vaccination Against Hypertension is Development Project No. 4 and has Already Been Awarded an FFG Grant of up to EUR 1.2 Million
PR Newswire Affitome(R) Technology is Being Used for the First Time Against Human Hormones | , February 25, 2010 /PRNewswire/ -- With immediate effect AFFiRiS AG is starting a development program for vaccination against hypertension. For this proje... |
Medivation to Host Conference Call at 8:30 a.m. Eastern Time Tomorrow to Discuss Phase 3 Trial Results for Dimebon in Alzheimer's Disease
PR Newswire | , March 2 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced that it will hold a teleconference and webcast at 8:30 a.m. Eastern Time tomorrow, Wednesday, March 3, to discuss Phase 3 trial results for dimebon (latrepir... |
No previous results
Next 20 results |
 |
